Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia of End Stage Renal Disease”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Not applicableStudy completedNCT01121237
What this trial is testing

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

Who this might be right for
Chronic Kidney DiseaseEnd-stage Renal DiseaseAnaemia
Sandoz 2,086
Testing effectiveness (Phase 2)Study completedNCT00434330
What this trial is testing

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 91
Large-scale testing (Phase 3)UnknownNCT00238043
What this trial is testing

Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia

Who this might be right for
Chronic Kidney DiseaseEnd-Stage Renal FailureAnaemia
Ministry of Health, Malaysia 2,000
Early research (Phase 1)Active Not RecruitingNCT06996717
What this trial is testing

Study of Rule-Based Algorithms in Anemia Management in Prevalent Hemodialysis Patients and Its Relation to Patients' Outcomes

Who this might be right for
Anemia in End Stage Renal Disease
Ain Shams University 145
Testing effectiveness (Phase 2)Ended earlyNCT00372489
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 81
Early research (Phase 1)Study completedNCT02327546
What this trial is testing

Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548

Who this might be right for
Healthy Volunteers
Akebia Therapeutics 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07160452
What this trial is testing

Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia

Who this might be right for
AnemiaKidney FailureEnd-Stage Renal Disease+1 more
Shaikh Zayed Hospital, Lahore 94
Not applicableStudy completedNCT00563355
What this trial is testing

Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

Who this might be right for
Chronic DiseaseKidney DiseasesCardiovascular Diseases
Hospital Authority, Hong Kong 66
Testing effectiveness (Phase 2)Study completedNCT01596855
What this trial is testing

Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China

Who this might be right for
Anemia in End Stage Renal Disease
Kyntra Bio 96
Post-approval studies (Phase 4)Study completedNCT00649298
What this trial is testing

A Clinical Trial of IntensiVE Dialysis

Who this might be right for
Renal Replacement TherapyRenal DialysisEnd Stage Kidney Disease+2 more
The George Institute 200
Large-scale testing (Phase 3)Study completedNCT04410198
What this trial is testing

Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants

Who this might be right for
Anemia Associated With End Stage Renal Disease (ESRD)
Kyntra Bio 203
Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94
Large-scale testing (Phase 3)Study completedNCT02273726
What this trial is testing

Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis

Who this might be right for
CKD Anemia in Stable Dialysis Patients
Kyntra Bio 741
Not applicableLooking for participantsNCT06906835
What this trial is testing

Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis

Who this might be right for
HemodialysisAnemia in End Stage Renal Disease
King Chulalongkorn Memorial Hospital 160
Large-scale testing (Phase 3)Study completedNCT01473420
What this trial is testing

Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Who this might be right for
Chronic Renal FailureChronic Kidney Disease
Pfizer 320
Large-scale testing (Phase 3)Study completedNCT04215120
What this trial is testing

Desidustat in the Treatment of Anemia in CKD on Dialysis Patients

Who this might be right for
Chronic Kidney Disease Stage 5 on Dialysis
Zydus Lifesciences Limited 392
Testing effectiveness (Phase 2)Study completedNCT02335593
What this trial is testing

Efficacy Study of Zinc Supplementation on Anemia, Oxidative Stress and Inflammation in Hemodialysis Patients

Who this might be right for
End Stage Renal Disease
Ain Shams University 64
Early research (Phase 1)Study completedNCT01978587
What this trial is testing

Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease

Who this might be right for
Anemia in Chronic Kidney Disease
Akros Pharma Inc. 6
Large-scale testing (Phase 3)Study completedNCT00261521
What this trial is testing

The Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients

Who this might be right for
Kidney Failure, ChronicAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 596
Not applicableStudy completedNCT00211029
What this trial is testing

Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

Who this might be right for
Red-Cell Aplasia, Pure
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4,670
Next Page